Pasithea Therapeutics Corp. Gains 52.15%
Thu, Sep 26, 2024 at 07:35 PM
Pasithea Therapeutics Corp. (KTTA:NASDAQ) shot up at $5.85, representing a gain of 52.1%. On Thu, Sep 26, 2024, KTTA:NASDAQ touched a New 2-Week High of $5.85. The stock got featured on our News Catalysts scanner on Thu, Sep 26, 2024 at 07:03 PM in the 'PRIVATE PLACEMENT' category. From Thu, Sep 12, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Sep 26, 2024 at $7.49 with a volume of 56M+.
About Pasithea Therapeutics Corp. (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- Fangdd Network Group Ltd. (DUO:NASDAQ), 109.97%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- Volato Group Inc. Class A (SOAR:NYSEMKT), 83.21%
- Translate Bio, Inc. (TBIO:NASDAQ), 71.98%
- Alpha Technology Group Limited (ATGL:NASDAQ), 71.16%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 52.15%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 50%
- CN Energy Group Inc. (CNEY:NASDAQ), 39.73%
- Nano Labs Ltd (NA:NASDAQ), 33.53%
- American Lithium Corp. (AMLI:NASDAQ), 33.33%